PIK3C2G and lung adenocarcinoma: Functional validation in A549 cells revealed that PIK3C2G knockdown suppressed proliferation, migration, and invasion while promoting apoptosis and disrupting cell cycle progression, thus supporting PIK3C2G as a potential therapeutic target, warranting further exploration of its role in lung adenocarcinoma.